Kozik, Violetta; Bak, Andrzej; Pentak, Danuta; Hachula, Barbara; Pytlakowska, Katarzyna; Rojkiewicz, Marcin; Jampilek, Josef; Sieron, Karolina; Jazowiecka-Rakus, Joanna; Sochanik, Aleksander published the artcile< Derivatives of graphene oxide as potential drug carriers>, Recommanded Product: Dimethyl 2,2′-azanediyldiacetate hydrochloride, the main research area is graphene oxide potential drug carrier.
Chem. functionalized graphene oxides could be used as novel drug carriers. Covalent alterations of graphene oxides lead to surface changes via formation of chem. bonding while non-covalent ones involve van der Waals forces, hydrogen bonding, and π-π stacking interactions. Covalent modifications appear to be superior as they can yield compounds with desired properties and carriers prepared by other methods are less stable. Synthesis of graphene oxide-iminodiacetic acid and graphene oxide-glycine involves nucleophilic substitution of graphene oxide nanoparticles with iminodiacetic acid or glycine. As the first step, iminodiacetic acid or glycine were transformed into iminodiacetic acid or glycine Me ester hydrochlorides, resp., for C-terminus protection. The obtained product, activated in situ, was then used to form amide bonds between graphene oxide and iminodiacetic acid or glycine.
Journal of Nanoscience and Nanotechnology published new progress about Amide group. 39987-25-2 belongs to class esters-buliding-blocks, and the molecular formula is C6H12ClNO4, Recommanded Product: Dimethyl 2,2′-azanediyldiacetate hydrochloride.
Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics